Neurocognitive impairment in patients with Fibromyalgia and Chronic Fatigue Syndrome
Settore scientifico disciplinare
MED/16
Corso di studi
FISIOPATOLOGIA MEDICA E FARMACOLOGIA
Relatori
tutor Prof. Bombardieri, Stefano
Parole chiave
Chronic Fatigue Syndrome
Fibromyalgia
Data inizio appello
22/10/2012
Consultabilità
Completa
Riassunto
Background: Fibromyalgia (FM) and chronic fatigue syndrome (CFS), two diseases that are frequently associated, are known to share many symptoms, which include pain - usually more pronounced in FM - and fatigue, together with mood, sleep and neurocognitive disorders. Symptoms as clouded mentation, forgetfulness and difficulty concentrating are very common and contribute to the disability of the disorders. These complaints are termed “fibrofog” and suggest that the central nervous system may be involved in the pathophysiology of the syndroms. Coexisting psychological distress or a psychiatric disorder also may contribute to neurocognitive deficits. Moreover literature data suggest that the peptide β amyloid, major constituent of amyloid plaques, is involved in neurodegenerative and psychiatric disorders as Alzheimer and depression.
Objective: The aim of the study was to investigate neurocognitive disorders in FMS and CFS patients also examining the influence of many clinical variables (i.e. pain, fatigue, mood and sleep disorders, drug assumption). Secondary objective was to evaluate the levels of β amyloid to better understand neurodegenerative impairments in these syndromes.